Monopar Therapeutics Inc (1IY0) Financial Statements

0 Followers

Monopar Therapeutics Inc Financial Overview

Monopar Therapeutics Inc's market cap is currently €659.56M. The company's EPS TTM is €-2.34; its P/E ratio is -48.03; Monopar Therapeutics Inc is scheduled to report earnings on August 12, 2026, and the estimated EPS forecast is €-0.69. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Mar 25	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -16.70M	$ -16.16M	$ -8.83M	$ -10.54M	$ -9.13M
EBITDA	$ -13.72M	$ -15.59M	$ -8.40M	$ -10.52M	$ -9.10M
Net Income	$ -13.72M	$ -15.59M	$ -8.40M	$ -10.52M	$ -9.10M
Balance Sheet
Cash & Short-Term Investments	$ 140.40M	$ 60.21M	$ 7.27M	$ 13.12M	$ 20.30M
Total Assets	$ 140.72M	$ 60.29M	$ 7.35M	$ 13.23M	$ 20.52M
Total Debt	$ 154.92K	$ 0.00	$ 0.00	$ 8.41K	$ 0.00
Net Debt	$ -61.68M	$ -45.82M	$ -7.27M	$ -8.18M	$ -20.30M
Total Liabilities	$ 2.89M	$ 5.25M	$ 1.76M	$ 3.14M	$ 1.58M
Stockholders' Equity	$ 137.83M	$ 55.04M	$ 5.59M	$ 10.09M	$ 18.94M
Cash Flow
Free Cash Flow	$ -12.20M	$ -6.40M	$ -7.86M	$ -7.23M	$ -7.32M
Operating Cash Flow	$ -12.20M	$ -6.40M	$ -7.86M	$ -7.23M	$ -7.32M
Investing Cash Flow	$ -63.45M	$ -14.34M	$ 4.93M	$ -4.92M	$ 0.00
Financing Cash Flow	$ 91.57M	$ 59.29M	$ 2.03M	$ 32.87K	$ 10.88M

Currency in USD

Monopar Therapeutics Inc Earnings and Revenue History

Income Statement >

Monopar Therapeutics Inc Debt to Assets

Balance Sheet >

Monopar Therapeutics Inc Cash Flow

Cash Flow >

Monopar Therapeutics Inc Forecast EPS vs Actual EPS

Earnings >